ArticleInflammation research : official journal of the European Histamine Research Society ... [et al.]2010

The selective COX-2 inhibitor Etoricoxib reduces acute inflammatory markers in a model of neurogenic laryngitis but loses its efficacy with prolonged treatment.

Manuel Lima-Rodrigues et al.PubMed ↗Publisher ↗

No numbers read from the abstract.